Register Login

CRYOPORT, INC. (CYRX)

SymbolCYRX
NameCRYOPORT, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Pharmaceutical Preparations
Address112 WESTWOOD PLACE,SUITE 350, BRENTWOOD, Tennessee, 37027, United States
Telephone+1 949 470-2300
Fax—
Email—
Websitehttps://www.cryoport.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001124524
Description

CryoPort Inc is a provider of a temperature-controlled supply chain for the life sciences industry by providing an evolving platform of critical products and solutions including advanced packaging, informatics, specialty logistics services, biostorage services, and cryogenic life sciences equipment. The company provides global solutions to the biopharma/pharma, animal health, and human reproductive medicine markets. Its primary focus is on addressing the critical temperature-controlled supply chain needs within the biopharmaceutical space with an emphasis on serving the rapidly growing cell and gene therapy market.

Additional info from NASDAQ:
CryoPort Inc is a provider of a temperature-controlled supply chain for the life sciences industry by providing an evolving platform of critical products and solutions including advanced packaging, informatics, specialty logistics services, biostorage services, and cryogenic life sciences equipment. The company provides global solutions to the biopharma/pharma, animal health, and human reproductive medicine markets. Its primary focus is on addressing the critical temperature-controlled supply chain needs within the biopharmaceutical space with an emphasis on serving the rapidly growing cell and gene therapy market.

2026-05-04 20:30

(30% Negative) CRYOPORT, INC. (CYRX) Reports Q2 2026 Financial Results

Read more
2026-05-04 20:05

Cryoport Reports First Quarter 2026 Financial Results

Read more
2026-04-24 00:00

Director SHELTON JERRELL 🟡 adjusted position in 0 shares (1 derivative) of Cryoport, Inc. (CYRX) at $1.87 Transaction Date: Apr 21, 2026 | Filing ID: 047945

Read more
2026-04-22 17:33

New Form ARS - Cryoport, Inc. <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001140361-26-016133 <b>Size:</b> 1 MB

Read more
2026-04-22 17:32

New Form DEFA14A - Cryoport, Inc. <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001140361-26-016132 <b>Size:</b> 6 MB

Read more
2026-04-22 17:31

New Form DEF 14A - Cryoport, Inc. <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001140361-26-016129 <b>Size:</b> 10 MB

Read more
2026-04-20 20:05

Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026

Read more
2026-04-08 22:32

Director SHELTON JERRELL 🟡 adjusted position in 0 shares (1 derivative) of Cryoport, Inc. (CYRX) at $1.87 Transaction Date: Apr 06, 2026 | Filing ID: 041041

Read more
2026-03-26 18:41

New Form SCHEDULE 13G/A - Cryoport, Inc. <b>Filed:</b> 2026-03-26 <b>AccNo:</b> 0000102909-26-001051 <b>Size:</b> 7 KB

Read more
2026-03-26 00:01

STEFANOVICH ROBERT 🔴 sold 1.1K shares of Cryoport, Inc. (CYRX) at $8.18 Transaction Date: Mar 23, 2026 | Filing ID: 034754

Read more